Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.54 |
| ▸ | YARS1 | P54577 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.38 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.38 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | XIAP | P98170 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27343864 | 1.00 | SLC7A5 (0.54) | SLC7A5YARS1HDAC8TAAR1SLC6A2 | |
| SCHEMBL7587110 | 0.89 | ALPI (0.51) | SLC7A5HDAC8ALPIPKMPTGS1 | |
| SCHEMBL27426539 | 0.89 | ALPI (0.51) | SLC7A5HDAC8ALPIPKMPTGS1 | |
| SCHEMBL8673016 | 0.86 | SLC7A5 (0.57) | SLC7A5YARS1HDAC8TAAR1SLC6A2 | |
| SCHEMBL9724064 | 0.86 | SLC7A5 (0.57) | SLC7A5YARS1HDAC8TAAR1SLC6A2 | |
| SCHEMBL27375801 | 0.86 | SLC7A5 (0.57) | SLC7A5YARS1HDAC8TAAR1SLC6A2 | |
| SCHEMBL30440024 | 0.78 | SLC7A5 (0.58) | SLC7A5YARS1HDAC8TAAR1SLC6A2 | |
| SCHEMBL7588100 | 0.77 | SLC7A5 (0.56) | SLC7A5YARS1HDAC8TAAR1SLC6A2 | |
| SCHEMBL28794185 | 0.77 | SLC7A5 (0.56) | SLC7A5YARS1HDAC8TAAR1SLC6A2 | |
| SCHEMBL28794174 | 0.77 | SLC7A5 (0.56) | SLC7A5YARS1HDAC8TAAR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0597838-B1 | VACCINE COMPOSITIONS | NORTH AMERICAN VACCINE INC (CA) | 1998-12-02 | — | — | EP | claimed |
| EP-0549617-B1 | IMPROVED VACCINE COMPOSITIONS | NORTH AMERICAN VACCINE INC (CA) | 1996-03-27 | — | — | EP | claimed |
| EP-0597838-A1 | VACCINE COMPOSITIONS | NORTH AMERICAN VACCINE, INC. (CA) | 1994-05-25 | — | — | EP | claimed |
| EP-0549617-A1 | IMPROVED VACCINE COMPOSITIONS. | NORTH AMERICAN VACCINE INC (CA) | 1993-07-07 | — | — | EP | claimed |
| CN-1060408-A | Improved vaccine combination | NORTH AMERICAN VACCINE INC (CA) | 1992-04-22 | — | — | CN | claimed |
| WO-1992004915-A1 | IMPROVED VACCINE COMPOSITIONS | NORTH AMERICAN VACCINE, INC. (CA) | 1992-04-02 | — | — | WO | claimed |
| CN-1056816-A | The vaccine combination of improvement | NORTH AMERICAN VACCINES INC (CA) | 1991-12-11 | — | — | CN | claimed |
| WO-1991016926-A1 | VACCINE COMPOSITIONS | NORTH AMERICAN VACCINE, INC. (CA) | 1991-11-14 | — | — | WO | claimed |
| CN-100333787-C | YG and YGG for use as medicaments for maintaining and improving immune response | GAUTRIBE M (US) | 2007-08-29 | — | — | CN | disclosed |
| CN-1644214-A | YG and YGG for use as medicaments for maintaining and improving immune response | GAUTRIBE M (US) | 2005-07-27 | — | — | CN | disclosed |
| US-6156555-A | Method of preparing an enzyme participating in C-terminal amidation | SHISEIDO COMPANY LTD. (JP) | 2000-12-05 | — | — | US | disclosed |
| EP-0666318-B1 | Enzyme participating in c-terminal amidation, and method of preparing same and use thereof | SHISEIDO CO LTD (JP) | 2000-11-29 | — | — | EP | disclosed |
| US-5871995-A | Purified enzymes participating in C-terminal amidation | SHISEIDO COMPANY, LTD. (JP) | 1999-02-16 | — | — | US | disclosed |
| EP-0884389-A1 | Enzyme participating in C-terminal amidation, and method of preparing same and use thereof | SHISEIDO COMPANY LIMITED (JP) | 1998-12-16 | — | — | EP | disclosed |
| EP-0103077-B1 | SUBSTITUTED DIPEPTIDES, METHODS FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, METHOD FOR MAKING SUCH PHARMACEUTICAL COMPOSITIONS | SCHERING CORPORATION (US) | 1988-05-18 | — | — | EP | disclosed |
| US-4721726-A | ANALGESICS | SCHERING CORPORATION (US) | 1988-01-26 | — | — | US | disclosed |
| EP-0117429-B1 | PHOSPHOROUS CONTAINING COMPOUNDS AS INHIBITORS OF ENKEPHALINASES | SCHERING CORPORATION (US) | 1987-09-02 | — | — | EP | disclosed |
| US-4610816-A | ANALGESICS | SCHERING CORPORATION (US) | 1986-09-09 | — | — | US | disclosed |
| EP-0117429-A1 | Phosphorous containing compounds as inhibitors of enkephalinases | SCHERING CORPORATION (US) | 1984-09-05 | — | — | EP | disclosed |
| EP-0103077-A2 | Substituted dipeptides, methods for their production, pharmaceutical compositions containing them, method for making such pharmaceutical compositions | SCHERING CORPORATION (US) | 1984-03-21 | — | — | EP | disclosed |